Back to search

Sweden· SE-20190125000024

Flurbiprofen Apelsin Reckitt Benckiser 8,75 mg Sugtablett

A medicinal product, registered in Sweden by Reckitt Benckiser Healthcare (Scandinavia) A/S.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedFlurbiprofen Apelsin Reckitt Benckise…ATC—REGISTER NO.SE-20190125000024PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Manufacturer
Reckitt Benckiser Healthcare (Scandinavia) A/S
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20190125000024

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/818eddb5-4e30-4ae8-b71e-5165d81510b8
GET /v1/drugs/818eddb5-4e30-4ae8-b71e-5165d81510b8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL"
  ],
  "se_npl_id": "20190125000024",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20190125000024",
  "product_doc_link": "https://docetp.mpa.se/LMF/Flurbiprofen%20Apelsin%20Reckitt%20Benckiser%208.75%20mg%20Lozenge%20SmPC_09001bee8234ea62.pdf"
}

See everything about Flurbiprofen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.